Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27M Sell
974,963
-372,587
-28% -$8.23M 1.71% 6
2026
Q1
$19.7M Buy
1,347,550
+387,432
+40% +$5.69M 1.53% 13
2025
Q4
$12.2M Buy
960,118
+16,022
+2% +$236K 0.97% 59
2025
Q3
$14.6M Sell
944,096
-60,772
-6% -$980K 1.12% 48
2025
Q2
$15.8M Buy
1,004,868
+294,578
+41% +$4.47M 1.37% 29
2025
Q1
$13.6M Buy
710,290
+124,540
+21% +$2.73M 1.33% 30
2024
Q4
$14M Sell
585,750
-76,486
-12% -$2.14M 1.37% 21
2024
Q3
$18.6M Buy
662,236
+33,502
+5% +$946K 1.71% 10
2024
Q2
$16.5M Buy
628,734
+4,978
+0.8% +$104K 1.57% 10
2024
Q1
$13.7M Buy
+623,756
New +$13.4M 1.22% 32

Other funds holding RXO

Penn Capital Management's RXO Position: Q2 2026 in Review

Penn Capital Management reduced its RXO (RXO) stake by 28% in Q2 2026, selling an estimated $8.23M and leaving 974,963 shares worth $27M. The position accounts for 1.71% of the portfolio, ranked #6.

Penn Capital Management first reported a position in RXO in Q1 2024 and has held it in 10 quarters since. 304 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Penn Capital Management held 974,963 shares of RXO worth $27M as of Q2 2026.
  • Penn Capital Management sold 372,587 RXO shares in Q2 2026, an estimated $8.23M.
  • RXO made up 1.71% of Penn Capital Management's portfolio in Q2 2026, its #6 holding.
  • Penn Capital Management first reported a position in RXO in Q1 2024 and has held it in 10 quarters since.
  • 304 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Penn Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.